Paper Details

  1. Home
  2. Paper Details

Comparison of mesalazine and balsalazide in induction and maintenance of remission in patients with ulcerative colitis: a meta-analysis.

Author: AbdollahiMohammad, NikfarShekoufeh, RahimiRoja, RezaieAli

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Balsalazide was more effective than mesalazine in inducing remission in patients with ulcerative colitis, but it had no benefit compared with mesalazine in preventing relapse. Adverse event rates were similar for both drugs.
Paper Details　
Original Abstract of the Article :
BACKGROUND: 5-Aminosalicylates are the standard treatment for induction and maintenance of remission in mild-to-moderate ulcerative colitis. In recent years, the 5-aminosalicylic acid-containing pro-drug balsalazide has been the focus of attention. AIM: To compare the efficacy and tolerance of bals...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s10620-008-0428-2

データ提供：米国国立医学図書館（NLM）

Mesalazine vs. Balsalazide: A Tale of Two 5-Aminosalicylates in Ulcerative Colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that can have a significant impact on quality of life. 5-Aminosalicylates (5-ASAs) are a mainstay of treatment for UC, and both mesalazine and balsalazide are commonly prescribed medications. This meta-analysis compares the efficacy and tolerability of these two 5-ASAs in treating UC. Researchers pooled data from multiple randomized controlled trials, assessing the effectiveness of mesalazine and balsalazide in inducing and maintaining remission in UC patients. Their analysis found that balsalazide may be more effective than mesalazine in inducing remission, but there was no significant difference in their ability to prevent relapse.

Balsalazide: A Potential Advantage in Inducing Remission

The meta-analysis suggests that balsalazide may have a slight edge over mesalazine in inducing remission in UC patients. However, the difference in relapse prevention rates was not statistically significant. This highlights the importance of individualizing treatment decisions based on the specific needs of each patient and considering factors such as disease severity and personal preferences.

Choosing the Right 5-ASA for Ulcerative Colitis

This meta-analysis provides valuable insights into the relative effectiveness and tolerability of mesalazine and balsalazide in treating UC. While balsalazide may have a slight advantage in inducing remission, it is crucial to consult with a qualified healthcare professional to determine the most appropriate treatment strategy for your individual needs. This will help you make informed decisions about your medication choices and ensure that you receive the best possible care for your UC.

Dr. Camel's Conclusion

This meta-analysis is like a camel caravan comparing two different paths through a vast desert, seeking the most effective route to UC remission. While balsalazide may provide a slightly smoother path to initial remission, the journey to sustained recovery requires careful consideration of individual needs and a collaborative approach with healthcare professionals.

Date :
  1. Date Completed 2009-03-31
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

18683049

DOI: Digital Object Identifier

10.1007/s10620-008-0428-2

Related Literature

Article Analysis
・Effects of balsalazide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.